PETMED EXPRESS INC Segments Disclosure
Twelve Months Ended | ||||||||||||||||||||
($ in thousands) | March 31, 2025 | 3/31/2024 (As Restated) | 3/31/2023 (As Restated) | |||||||||||||||||
| Net Sales | $ | 226,972 | $ | 274,095 | $ | 247,569 | ||||||||||||||
| Significant expense categories: | ||||||||||||||||||||
| Cost of sales | 157,835 | 189,327 | 171,068 | |||||||||||||||||
| Advertising | 23,781 | 30,628 | 25,190 | |||||||||||||||||
Other segment expenses (1) | 44,684 | 45,895 | 31,541 | |||||||||||||||||
| Adjusted EBITDA | $672 | $8,245 | $19,770 | |||||||||||||||||
| (Add) subtract: | ||||||||||||||||||||
| Share-based compensation (reversal) expense | (6,586) | 6,870 | 6,617 | |||||||||||||||||
| Income taxes | 5,684 | 1,191 | 2,305 | |||||||||||||||||
| Depreciation and amortization | 7,039 | 7,056 | 3,546 | |||||||||||||||||
| Interest income | (185) | (511) | (450) | |||||||||||||||||
| Acquisition/Partnership transactions and other items | 231 | 1,679 | 1,904 | |||||||||||||||||
| Employee severance | 738 | 512 | 364 | |||||||||||||||||
Sales tax expense (reversal) (2) | (1,178) | (1,088) | 344 | |||||||||||||||||
| Impairment loss | 1,200 | — | — | |||||||||||||||||
| Net (loss) income | $ | (6,271) | $ | (7,464) | $ | 5,140 | ||||||||||||||
Want the next PETMED EXPRESS INC segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment PETMED EXPRESS INC's next filing hits EDGAR. No credit card, your email never gets sold.
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.